To read the full story
BUSINESS
- Novartis Adjusts Entresto Shipments Ahead of Price Hike in Off-Year Revision
March 7, 2025
- Off-Year Revision Is Problematic, Leads to Hesitation in Investment: Novo CEO
March 7, 2025
- Keytruda Tops Japan Drug Ranking for 17th Months on End: Encise
March 7, 2025
- Maruishi Files Midazolam Oral Syrup for Pediatric Use
March 7, 2025
- J&J Files Tremfya SC Induction Regimen for UC in Japan
March 7, 2025
1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…